Eli Lilly Announces Executive Leadership Changes to Support Continued Growth

Eli Lilly and Company announced key executive leadership transitions aimed at reinforcing its long-term growth strategy and expanding global access to its medicines. Ilya Yuffa will become EVP and President of Lilly USA and Global Customer Capabilities, leading U.S. operations and upcoming product launches. Patrik Jonsson, previously heading both cardiometabolic and U.S. operations, will now serve as EVP and President of Lilly International, overseeing markets outside the U.S.

Kenneth Custer, Ph.D., currently General Manager of Lilly Canada, will be promoted to EVP and President of Lilly Cardiometabolic Health, joining Lilly’s executive committee. A 16-year veteran, Custer brings experience from both commercial and research roles, including leading development programs in diabetes and immunology.

CEO David A. Ricks emphasized the changes will sharpen Lilly's focus and support its mission to deliver innovative medicines globally. The appointments reflect Lilly’s confidence in its leaders’ ability to drive its next phase of growth in cardiometabolic health, U.S. markets, and international expansion.